Delivery Order SPE2DB20D3101-SPE2DB24FRLS2

Award Date 6/3/24
Potential Completion Date 6/4/24
Potential Value $8.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $8,347.55, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award is for the delivery of Lidocaine 5% patches, valued at $3,445.45. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is a $999,999,999 contract running through November 2026 that provides a comprehensive range of pharmaceutical products...
This federal contract award is for the delivery of Lidocaine 5% Patches to the Defense Logistics Agency (DLA), a major procurement agency within the U.S. Department of Defense. The prime contractor, Amerisourcebergen Drug Corp, was awarded a Firm Fixed Price Delivery Order valued at $2,093.83 with a completion date of February 7, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00...
The federal contract award is for the delivery of Lidocaine 5% Patch, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on January 2, 2024, with a completion date of January 3, 2024 and a ceiling value of $17,683.23. This delivery order contract is awarded under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This federal contract award is for the delivery of Lidocaine 5% Patches, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 28, 2024 with a ceiling value of $1,870.47 and a completion date of May 29, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Lidocaine 5% Patches to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 26, 2024, with a ceiling value of $1,055.16. The contract is a Firm Fixed Price Delivery Order, with a period of performance through February 27, 2024. There is no set-aside designation for this...
This federal contract award is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA). The prime contractor is AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $6,657.94 and an ultimate completion date of October 21, 2024. The contract is not set aside for any special designation. AmerisourceBergen holds a broader Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of Lidocaine 5% Patches to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, as a delivery order under an Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999. The contract does not have a set-aside designation, indicating open competition. The total ceiling value of this specific delivery order is $4,346.67, with a firm fixed price pricing type. The...
This federal contract award is for the delivery of Lidocaine 5% Patches, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,038.59 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 21, 2023, with a completion date of November 22, 2023. The contract is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract, valued at $2,871.79, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRLS2
    Delivery Order

The federal contract award is for the delivery of Lidocaine 5% Patches, with a contract value of $8,341.71 and a completion date of June 4, 2024. The award was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency under the Department of Defense.

This award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 12:33 PM